MedPath

海达舍画阁药业有限公司

Ownership
-
Established
2009-07-30
Employees
-
Market Cap
-
Website
http://www.hdshgyy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Memantine Hydrochloride Oral Solution

Product Name
盐酸美金刚口服溶液
Approval Number
国药准字H20183420
Approval Date
Nov 27, 2023
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20234294
Approval Date
Oct 18, 2023
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20234295
Approval Date
Oct 18, 2023
NMPA

Atomoxetine Hydrochloride Oral Solution

Product Name
盐酸托莫西汀口服溶液
Approval Number
国药准字H20234055
Approval Date
Aug 29, 2023
NMPA

Lacosamide Oral Solution

Product Name
拉考沙胺口服溶液
Approval Number
国药准字H20234028
Approval Date
Aug 8, 2023
NMPA

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20183185
Approval Date
Jun 6, 2023
NMPA

不适用

Product Name
三味化瘀胶囊
Approval Number
国药准字Z20123089
Approval Date
Jan 12, 2023
NMPA

Levetiracetam Oral Solution

Product Name
左乙拉西坦口服溶液
Approval Number
国药准字H20213334
Approval Date
May 11, 2021
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath